cl 387785 has been researched along with Cell Transformation, Neoplastic in 1 studies
CL 387785: structure in first source
N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide : A member of the class of quinazolines that is 4,6-diaminoquinazoine in which the one of the hydrogens attached to the amino group at position 4 has been replaced by a m-bromophenyl group while one of the hydrogens attached to the amino group at position 6 has been replaced by a but-2-ynoyl group.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greulich, H | 1 |
| Chen, TH | 1 |
| Feng, W | 1 |
| Jänne, PA | 1 |
| Alvarez, JV | 1 |
| Zappaterra, M | 1 |
| Bulmer, SE | 1 |
| Frank, DA | 1 |
| Hahn, WC | 1 |
| Sellers, WR | 1 |
| Meyerson, M | 1 |
1 other study available for cl 387785 and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Cell Transformation, Neoplasti | 2005 |